Aclaris Therapeutics, Inc.

NasdaqGS:ACRS Stock Report

Market Cap: US$462.2m

Aclaris Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

NasdaqGS:ACRS Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
19 Nov 24BuyUS$1,499,999Anand MehraIndividual666,666US$2.25
05 Aug 24BuyUS$472,757BML Capital Management, LLCCompany373,569US$1.29
31 Jul 24BuyUS$359,010BML Capital Management, LLCCompany273,730US$1.33
22 Jul 24BuyUS$201,808BML Capital Management, LLCCompany154,722US$1.33
05 Jul 24BuyUS$405,894BML Capital Management, LLCCompany352,397US$1.16
01 Jul 24BuyUS$1,742,075BML Capital Management, LLCCompany1,543,434US$1.15
18 Jun 24BuyUS$628,206BML Capital Management, LLCCompany545,000US$1.17
13 Jun 24BuyUS$1,781,897BML Capital Management, LLCCompany1,611,200US$1.15
04 Mar 24BuyUS$17,955Andrew Kenneth PowellIndividual14,500US$1.25

Insider Trading Volume

Insider Buying: ACRS insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of ACRS?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders2,566,2253.59%
Hedge Funds14,250,00019.9%
General Public16,761,57223.5%
Institutions37,853,14553%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 51%.


Top Shareholders

Top 25 shareholders own 69.84% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
20%
BML Capital Management, LLC
14,250,000US$92.2m9.72%30.83%
6.56%
The Vanguard Group, Inc.
4,685,498US$30.3m-0.04%no data
4.72%
D. E. Shaw & Co., L.P.
3,371,849US$21.8m1.56%0.02%
4.21%
Millennium Management LLC
3,005,598US$19.4m-9.93%0.01%
3.85%
Rock Springs Capital Management LP
2,753,495US$17.8m0%0.43%
3.44%
Stonepine Capital Management LLC
2,458,873US$15.9m27.6%3.88%
2.91%
Acadian Asset Management LLC
2,078,287US$13.4m8.61%0.02%
2.68%
Trium Capital Managers Ltd
1,912,990US$12.4m1.11%4.65%
2.4%
BlackRock, Inc.
1,711,797US$11.1m-15.8%no data
1.93%
Neal Walker
1,376,388US$8.9m0.99%no data
1.92%
Renaissance Technologies LLC
1,370,700US$8.9m48.6%0.01%
1.82%
Two Sigma Advisers, LP
1,301,500US$8.4m-9.42%0.01%
1.46%
Aldebaran Capital, LLC
1,043,152US$6.7m21.6%4.15%
1.35%
PEH Wertpapier AG
963,544US$6.2m0%0.3%
1.29%
Deutsche Asset & Wealth Management
923,313US$6.0m0%no data
1.28%
Jacobs Levy Equity Management Inc
915,509US$5.9m0%0.02%
1.27%
Two Sigma Investments, LP
907,916US$5.9m-18.4%0.01%
1.18%
Geode Capital Management, LLC
846,446US$5.5m9.34%no data
0.99%
Anand Mehra
710,030US$4.6m1,540%no data
0.97%
Samsara BioCapital LLC
696,171US$4.5m0%0.46%
0.81%
Acuitas Investments, LLC
578,139US$3.7m24.6%0.8%
0.8%
Palo Alto Investors LP
569,832US$3.7m0%0.37%
0.76%
FMR LLC
545,972US$3.5m-20.8%no data
0.67%
Morgan Stanley, Investment Banking and Brokerage Investments
477,557US$3.1m167%no data
0.61%
Aisling Capital Management LP
434,455US$2.8m0%0.81%